{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T10:49:02Z","timestamp":1794998942569,"version":"4.9.1"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.rmed.2026.108736","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T07:48:05Z","timestamp":1772178485000},"page":"108736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Treatable traits and treatment options in asthma"],"prefix":"10.1016","volume":"254","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3783-2244","authenticated-orcid":false,"given":"Shivani Setur","family":"Kanabar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian Douglas","family":"Pavord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy Stopford Christopher","family":"Hinks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2026.108736_bib1","series-title":"Global Strategy for Asthma Management and Prevention","year":"2023"},{"issue":"9643","key":"10.1016\/j.rmed.2026.108736_bib2","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(08)61452-X","article-title":"Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease","volume":"372","author":"Anderson","year":"2008","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.rmed.2026.108736_bib3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jaci.2015.01.014","article-title":"Innate and adaptive T cells in asthmatic patients: relationship to severity and disease mechanisms","volume":"136","author":"Hinks","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.rmed.2026.108736_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jaci.2015.11.020","article-title":"Multidimensional endotyping in patients with severe asthma reveals inflammatory heterogeneity in matrix metalloproteinases and chitinase 3-like protein 1","volume":"138","author":"Hinks","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.rmed.2026.108736_bib5","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1164\/rccm.200711-1754OC","article-title":"Cluster analysis and clinical asthma phenotypes","volume":"178","author":"Haldar","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.rmed.2026.108736_bib6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1164\/rccm.201512-2452OC","article-title":"\u2021, A transcriptome-driven analysis of epithelial brushings and bronchial biopsies to define asthma phenotypes in U-BIOPRED","volume":"195","author":"Kuo","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"10118","key":"10.1016\/j.rmed.2026.108736_bib7","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(17)30879-6","article-title":"After asthma: redefining airways diseases","volume":"391","author":"Pavord","year":"2018","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.rmed.2026.108736_bib8","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa0808991","article-title":"Mepolizumab and exacerbations of refractory eosinophilic asthma","volume":"360","author":"Haldar","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"9842","key":"10.1016\/j.rmed.2026.108736_bib9","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","article-title":"Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial","volume":"380","author":"Pavord","year":"2012","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.rmed.2026.108736_bib10","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1164\/rccm.200701-085OC","article-title":"A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma","volume":"176","author":"Flood-Page","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"9248","key":"10.1016\/j.rmed.2026.108736_bib11","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/S0140-6736(00)03496-6","article-title":"Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response","volume":"356","author":"Leckie","year":"2000","journal-title":"Lancet"},{"issue":"9537","key":"10.1016\/j.rmed.2026.108736_bib12","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0140-6736(06)69284-2","article-title":"Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study","volume":"368","author":"Rabe","year":"2006","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.rmed.2026.108736_bib13","first-page":"CD013518","article-title":"Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma","volume":"5","author":"Crossingham","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.rmed.2026.108736_bib14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/thoraxjnl-2012-202606","article-title":"Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the \u03b22 agonist vilanterol administered once daily for 52 weeks in patients >=12 years old with asthma: a randomised trial","volume":"68","author":"Busse","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2026.108736_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.rmed.2018.06.009","article-title":"Efficacy and safety of once-daily fluticasone furoate\/vilanterol (FF\/VI) versus twice-daily inhaled corticosteroids\/long-acting \u03b2","volume":"141","author":"Devillier","year":"2018","journal-title":"Respir. Med."},{"issue":"4","key":"10.1016\/j.rmed.2026.108736_bib16","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.immuni.2019.03.018","article-title":"The cytokines of asthma","volume":"50","author":"Lambrecht","year":"2019","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.rmed.2026.108736_bib17","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1111\/all.16146","article-title":"The effects of inhaled corticosteroids on healthy airways","volume":"79","author":"Marchi","year":"2024","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.rmed.2026.108736_bib18","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/resp.14294","article-title":"Sub-stratification of type-2 high airway disease for therapeutic decision-making: a 'bomb' (blood eosinophils) meets 'magnet' (FeNO) framework","volume":"27","author":"Couillard","year":"2022","journal-title":"Respirology"},{"issue":"6","key":"10.1016\/j.rmed.2026.108736_bib19","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.chest.2021.07.008","article-title":"Workup of severe asthma","volume":"160","author":"Couillard","year":"2021","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.rmed.2026.108736_bib20","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1164\/rccm.202104-1040LE","article-title":"Fractional exhaled nitric oxide nonsuppression identifies corticosteroid-resistant type 2 signaling in severe asthma","volume":"204","author":"Couillard","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.rmed.2026.108736_bib21","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S2213-2600(25)00037-2","article-title":"Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials","volume":"13","author":"Meulmeester","year":"2025","journal-title":"Lancet Respir. Med."},{"issue":"5","key":"10.1016\/j.rmed.2026.108736_bib22","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1056\/NEJM200008033430504","article-title":"Low-dose inhaled corticosteroids and the prevention of death from asthma","volume":"343","author":"Suissa","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.rmed.2026.108736_bib23","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1164\/rccm.201810-1868CI","article-title":"Inhaled corticosteroid therapy in adult asthma. Time for a new therapeutic dose terminology","volume":"199","author":"Beasley","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.rmed.2026.108736_bib24","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1164\/rccm.201806-1182OC","article-title":"Remotely monitored therapy and nitric oxide suppression identifies nonadherence in severe asthma","volume":"199","author":"Heaney","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"10","key":"10.1016\/j.rmed.2026.108736_bib25","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1164\/rccm.201903-0599LE","article-title":"Prognostic and predictive value of blood Eosinophil Count, Fractional exhaled nitric oxide, and their combination in severe asthma: a","volume":"200","author":"Shrimanker","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"19","key":"10.1016\/j.rmed.2026.108736_bib26","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa2034975","article-title":"Tezepelumab in adults and adolescents with severe, uncontrolled asthma","volume":"384","author":"Menzies-Gow","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.rmed.2026.108736_bib27","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1164\/rccm.202003-0729LE","article-title":"Blood eosinophil depletion with mepolizumab, Benralizumab, and prednisolone in eosinophilic asthma","volume":"202","author":"Moran","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2026.108736_bib28","article-title":"Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study","volume":"357","author":"Waljee","year":"2017","journal-title":"Br. Med. J."},{"issue":"7","key":"10.1016\/j.rmed.2026.108736_bib29","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S2213-2600(16)30031-5","article-title":"Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies","volume":"4","author":"Ortega","year":"2016","journal-title":"Lancet Respir. Med."},{"issue":"13","key":"10.1016\/j.rmed.2026.108736_bib30","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"25","key":"10.1016\/j.rmed.2026.108736_bib31","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1056\/NEJMoa1703501","article-title":"Oral glucocorticoid-sparing effect of benralizumab in severe asthma","volume":"376","author":"Nair","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.rmed.2026.108736_bib32","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S2213-2600(15)00042-9","article-title":"Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials","volume":"3","author":"Castro","year":"2015","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.108736_bib33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S2213-2600(20)30397-0","article-title":"Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial","volume":"9","author":"Heaney","year":"2021","journal-title":"Lancet Respir. Med."},{"issue":"2","key":"10.1016\/j.rmed.2026.108736_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02279-21","article-title":"Identifying bacterial airways infection in stable severe asthma using Oxford nanopore sequencing technologies","volume":"10","author":"Jabeen","year":"2022","journal-title":"Microbiol. Spectr."},{"issue":"11","key":"10.1016\/j.rmed.2026.108736_bib35","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1111\/all.16269","article-title":"Species-level, metagenomic and proteomic analysis of microbe-immune interactions in severe asthma","volume":"79","author":"Jabeen","year":"2024","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.rmed.2026.108736_bib36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/thx.2006.061358","article-title":"Innate immune activation in neutrophilic asthma and bronchiectasis","volume":"62","author":"Simpson","year":"2007","journal-title":"Thorax"},{"issue":"165","key":"10.1016\/j.rmed.2026.108736_bib37","article-title":"Non-typeable","volume":"31","author":"Brown","year":"2022","journal-title":"Eur. Respir. Rev."},{"issue":"4","key":"10.1016\/j.rmed.2026.108736_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftx042","article-title":"Insights on persistent airway infection by non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease","volume":"75","author":"Ahearn","year":"2017","journal-title":"Pathog Dis"},{"key":"10.1016\/j.rmed.2026.108736_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1141798","article-title":"Epithelial immune activation and intracellular invasion by non-typeable","volume":"13","author":"Brown","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.rmed.2026.108736_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2011.00001","article-title":"Non-typeable Haemophilus influenzae invasion and persistence in the human respiratory tract","volume":"1","author":"Clementi","year":"2011","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"10095","key":"10.1016\/j.rmed.2026.108736_bib41","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(17)31281-3","article-title":"Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Gibson","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.rmed.2026.108736_bib42","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1164\/rccm.201809-1739OC","article-title":"Long-Term azithromycin reduces Haemophilus influenzae and increases antibiotic resistance in severe asthma","volume":"200","author":"Taylor","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.rmed.2026.108736_bib43","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00194-2020","article-title":"Airway abundance of Haemophilus influenzae predicts response to azithromycin in adults with persistent uncontrolled asthma","volume":"56","author":"Taylor","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2026.108736_bib44","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00588-2019","article-title":"Management of severe asthma: a European Respiratory Society\/American Thoracic Society guideline","volume":"55","author":"Holguin","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.rmed.2026.108736_bib45","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S2213-2600(13)70038-9","article-title":"Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases","volume":"1","author":"Serisier","year":"2013","journal-title":"Lancet Respir. Med."},{"issue":"2","key":"10.1016\/j.rmed.2026.108736_bib46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/thorax-2024-221977","article-title":"Effects of azithromycin in severe eosinophilic asthma with concomitant monoclonal antibody treatment","volume":"80","author":"Lavoie","year":"2025","journal-title":"Thorax"},{"issue":"24","key":"10.1016\/j.rmed.2026.108736_bib47","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1001\/jama.2021.7872","article-title":"Triple vs dual inhaler therapy and asthma outcomes in moderate to severe asthma: a systematic review and meta-analysis","volume":"325","author":"Kim","year":"2021","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.rmed.2026.108736_bib48","first-page":"CD013799","article-title":"Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and varying doses of inhaled corticosteroids in adolescents and adults with asthma: a systematic review and network meta-analysis","volume":"12","author":"Oba","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.rmed.2026.108736_bib49","article-title":"Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA\/ICS) versus LABA\/ICS for adults with asthma","volume":"2016","author":"Kew","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"33","key":"10.1016\/j.rmed.2026.108736_bib50","article-title":"Efficacy of tiotropium in treating patients with moderate-to-severe asthma: a meta-analysis and systematic review based on 14 randomized controlled trials","volume":"98","author":"Meng","year":"2019","journal-title":"Medicine (Baltim.)"},{"issue":"2","key":"10.1016\/j.rmed.2026.108736_bib51","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/all.13629","article-title":"Treatable traits in the European U-BIOPRED adult asthma cohorts","volume":"74","author":"Simpson","year":"2019","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.rmed.2026.108736_bib52","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1183\/13993003.00779-2015","article-title":"Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort","volume":"46","author":"Shaw","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.rmed.2026.108736_bib53","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3121\/cmr.2013.1113","article-title":"Patient characteristics associated with medication adherence","volume":"11","author":"Rolnick","year":"2013","journal-title":"Clin. Med. Res."},{"issue":"10","key":"10.1016\/j.rmed.2026.108736_bib54","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1136\/thorax.57.10.880","article-title":"Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma","volume":"57","author":"Suissa","year":"2002","journal-title":"Thorax"},{"issue":"8","key":"10.1016\/j.rmed.2026.108736_bib55","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/thoraxjnl-2011-201096","article-title":"The relationship between clinical outcomes and medication adherence in difficult-to-control asthma","volume":"67","author":"Murphy","year":"2012","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.rmed.2026.108736_bib56","doi-asserted-by":"crossref","first-page":"818","DOI":"10.4187\/respcare.05905","article-title":"Adherence in asthma and COPD: new strategies for an old problem","volume":"63","author":"George","year":"2018","journal-title":"Respir. Care"},{"issue":"10","key":"10.1016\/j.rmed.2026.108736_bib57","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.rmed.2013.04.005","article-title":"Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD","volume":"107","author":"M\u00e4kel\u00e4","year":"2013","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.rmed.2026.108736_bib58","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00485-2018","article-title":"Pharmacists and medication adherence in asthma: a systematic review and meta-analysis","volume":"52","author":"Mes","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"9","key":"10.1016\/j.rmed.2026.108736_bib59","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.rmed.2011.03.019","article-title":"A study of a multi-level intervention to improve non-adherence in difficult to control asthma","volume":"105","author":"Gamble","year":"2011","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2026.108736_bib60","series-title":"Asthma: Diagnosis, Monitoring and Chronic Asthma Management (BTS, NICE, SIGN)","year":"2024"},{"issue":"1","key":"10.1016\/j.rmed.2026.108736_bib61","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S2213-2600(13)70012-2","article-title":"Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial","volume":"1","author":"Papi","year":"2013","journal-title":"Lancet Respir. Med."},{"issue":"12","key":"10.1016\/j.rmed.2026.108736_bib62","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1016\/j.rmed.2007.07.014","article-title":"Budesonide\/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol\/fluticasone","volume":"101","author":"Bousquet","year":"2007","journal-title":"Respir. Med."},{"issue":"4","key":"10.1016\/j.rmed.2026.108736_bib63","first-page":"CD007313","article-title":"Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children","volume":"2013","author":"Cates","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.rmed.2026.108736_bib64","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.0615","article-title":"Evaluation of budesonide-formoterol for maintenance and reliever therapy among patients with poorly controlled asthma: a systematic review and meta-analysis","volume":"5","author":"Beasley","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"4","key":"10.1016\/j.rmed.2026.108736_bib65","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s40265-015-0354-5","article-title":"Fluticasone furoate\/vilanterol: a review of its use in patients with asthma","volume":"75","author":"Syed","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.rmed.2026.108736_bib66","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.rmed.2018.06.003","article-title":"Patient-reported outcomes with initiation of fluticasone furoate\/vilanterol versus continuing usual care in the Asthma Salford Lung Study","volume":"141","author":"Svedsater","year":"2018","journal-title":"Respir. Med."},{"issue":"10109","key":"10.1016\/j.rmed.2026.108736_bib67","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/S0140-6736(17)32397-8","article-title":"Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice: an open-label, parallel group, randomised controlled trial","volume":"390","author":"Woodcock","year":"2017","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.rmed.2026.108736_bib68","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1080\/02770903.2017.1386214","article-title":"Once-daily fluticasone furoate\/vilanterol versus twice-daily fluticasone propionate\/salmeterol in patients with asthma well controlled on ICS\/LABA","volume":"55","author":"Bernstein","year":"2018","journal-title":"J. Asthma"},{"issue":"5","key":"10.1016\/j.rmed.2026.108736_bib69","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.21037\/jtd-19-3913","article-title":"Real-life effectiveness of fluticasone furoate\/vilanterol after switching from fluticasone\/salmeterol or budesonide\/formoterol therapy in patients with symptomatic asthma: Relvar Ellipta for real Asthma Control Study (RERACS study)","volume":"12","author":"Shimizu","year":"2020","journal-title":"J. Thorac. Dis."},{"issue":"6","key":"10.1016\/j.rmed.2026.108736_bib70","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1007\/s12325-020-01344-8","article-title":"Persistence and adherence to ICS\/LABA drugs in UK patients with asthma: a retrospective new-user cohort Study","volume":"37","author":"Parimi","year":"2020","journal-title":"Adv. Ther."},{"issue":"5","key":"10.1016\/j.rmed.2026.108736_bib71","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.jaip.2018.12.021","article-title":"Assessment of adherence and asthma medication ratio for a once-daily and twice-daily inhaled Corticosteroid\/Long-Acting \u03b2-Agonist for asthma","volume":"7","author":"Stanford","year":"2019","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"164","key":"10.1016\/j.rmed.2026.108736_bib72","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0271-2021","article-title":"Assessing adherence to inhaled therapies in asthma and the emergence of electronic monitoring devices","volume":"31","author":"Dhruve","year":"2022","journal-title":"Eur. Respir. Rev."},{"issue":"6","key":"10.1016\/j.rmed.2026.108736_bib73","first-page":"CD013030","article-title":"Digital interventions to improve adherence to maintenance medication in asthma","volume":"6","author":"Chan","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"issue":"7","key":"10.1016\/j.rmed.2026.108736_bib74","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.jaip.2025.04.039","article-title":"Patient-Facing digital inhalers for asthma: a systematic review and meta-analysis","volume":"13","author":"Ologundudu","year":"2025","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"141","key":"10.1016\/j.rmed.2026.108736_bib75","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1183\/16000617.0088-2015","article-title":"Dysfunctional breathing: a review of the literature and proposal for classification","volume":"25","author":"Boulding","year":"2016","journal-title":"Eur. Respir. Rev."},{"issue":"5","key":"10.1016\/j.rmed.2026.108736_bib76","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.jaip.2018.11.037","article-title":"Factors associated with dysfunctional breathing in patients with difficult to treat asthma","volume":"7","author":"Denton","year":"2019","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"4","key":"10.1016\/j.rmed.2026.108736_bib77","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jaip.2023.11.036","article-title":"Associations of breathing pattern disorder and nijmegen Score with clinical outcomes in difficult-to-treat asthma","volume":"12","author":"Freeman","year":"2024","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"1","key":"10.1016\/j.rmed.2026.108736_bib78","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2022-001395","article-title":"Physiotherapy assessment of breathing pattern disorder: a qualitative evaluation","volume":"10","author":"Grillo","year":"2023","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.rmed.2026.108736_bib79","doi-asserted-by":"crossref","DOI":"10.2196\/44453","article-title":"Experiences of diagnosis, symptoms, and use of reliever inhalers in patients with asthma and concurrent inducible laryngeal obstruction or breathing pattern disorder: qualitative analysis of a UK asthma online community","volume":"25","author":"Byrne","year":"2023","journal-title":"J. Med. Internet Res."},{"issue":"2","key":"10.1016\/j.rmed.2026.108736_bib80","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0022-3999(85)90042-X","article-title":"Efficacy of Nijmegen Questionnaire in recognition of the hyperventilation syndrome","volume":"29","author":"van Dixhoorn","year":"1985","journal-title":"J. Psychosom. Res."},{"issue":"8","key":"10.1016\/j.rmed.2026.108736_bib81","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3109\/02770903.2014.922190","article-title":"Hyperventilation in asthma: a validation study of the Nijmegen Questionnaire--NQ","volume":"51","author":"Grammatopoulou","year":"2014","journal-title":"J. Asthma"},{"issue":"8","key":"10.1016\/j.rmed.2026.108736_bib82","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.jaip.2025.04.033","article-title":"Diagnosis of dysfunctional breathing in severe asthma","volume":"13","author":"Soumagne","year":"2025","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"3","key":"10.1016\/j.rmed.2026.108736_bib83","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/resp.13173","article-title":"Novel assessment tool to detect breathing pattern disorder in patients with refractory asthma","volume":"23","author":"Todd","year":"2018","journal-title":"Respirology"},{"issue":"5","key":"10.1016\/j.rmed.2026.108736_bib84","first-page":"CD009041","article-title":"Breathing exercises for dysfunctional breathing\/hyperventilation syndrome in adults","volume":"2013","author":"Jones","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"9","key":"10.1016\/j.rmed.2026.108736_bib85","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1513\/AnnalsATS.202111-1228OC","article-title":"Breathing exercises for patients with asthma in specialist care: a multicenter randomized clinical trial","volume":"19","author":"Andreasson","year":"2022","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"6","key":"10.1016\/j.rmed.2026.108736_bib86","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.jaci.2023.08.028","article-title":"VCD and ILO are not synonymous","volume":"152","author":"Weinberger","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.rmed.2026.108736_bib87","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3109\/02770903.2014.982288","article-title":"Vocal cord dysfunction in bronchial asthma. A review article","volume":"52","author":"Idrees","year":"2015","journal-title":"J. Asthma"},{"issue":"4","key":"10.1016\/j.rmed.2026.108736_bib88","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jaci.2023.06.007","article-title":"Diagnosis of vocal cord dysfunction\/inducible laryngeal obstruction: an International Delphi Consensus Study","volume":"152","author":"Leong","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.rmed.2026.108736_bib89","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.jaci.2019.12.906","article-title":"Prevalence and impact of comorbid laryngeal dysfunction in asthma: a systematic review and meta-analysis","volume":"145","author":"Lee","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.rmed.2026.108736_bib90","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.jaip.2024.01.030","article-title":"Clinical characteristics and impact of inducible laryngeal obstruction in the UK national registry","volume":"12","author":"Haines","year":"2024","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"5","key":"10.1016\/j.rmed.2026.108736_bib91","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.jaip.2024.01.028","article-title":"Living with asthma and vocal cord Dysfunction\/Inducible laryngeal obstruction: \"I Just Can't Get Air In\"","volume":"12","author":"Majellano","year":"2024","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"3","key":"10.1016\/j.rmed.2026.108736_bib92","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02221-2016","article-title":"Inducible laryngeal obstruction: an official joint European Respiratory Society and European Laryngological Society statement","volume":"50","author":"Halvorsen","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.rmed.2026.108736_bib93","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00774-2024","article-title":"Protocol for a double-blind crossover randomised controlled trial to investigate inhalation challenge to assess inducible laryngeal obstruction: CH-ILO","volume":"11","author":"Haines","year":"2025","journal-title":"ERJ Open Res"},{"issue":"6","key":"10.1016\/j.rmed.2026.108736_bib94","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00707-2023","article-title":"Vocal cord dysfunction\/inducible laryngeal obstruction cannot be diagnosed from symptoms","volume":"9","author":"Yap","year":"2023","journal-title":"ERJ Open Res"},{"issue":"1","key":"10.1016\/j.rmed.2026.108736_bib95","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jaip.2013.09.002","article-title":"A novel scoring system to distinguish vocal cord dysfunction from asthma","volume":"2","author":"Traister","year":"2014","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"9","key":"10.1016\/j.rmed.2026.108736_bib96","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/cea.12550","article-title":"The VCDQ--a Questionnaire for symptom monitoring in vocal cord dysfunction","volume":"45","author":"Fowler","year":"2015","journal-title":"Clin. Exp. Allergy"},{"issue":"1","key":"10.1016\/j.rmed.2026.108736_bib97","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200183","article-title":"Computed tomography imaging of the larynx for diagnosis of vocal cord dysfunction","volume":"2","author":"Koh","year":"2023","journal-title":"NEJM Evid."},{"issue":"1","key":"10.1016\/j.rmed.2026.108736_bib98","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDe2200299","article-title":"Take a deep breath - time to Plunge into inducible laryngeal obstruction","volume":"2","author":"Melhorn","year":"2023","journal-title":"NEJM Evid."},{"key":"10.1016\/j.rmed.2026.108736_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2024.107905","article-title":"Peripheral airways dysfunction measured by oscillometry differentiates asthma from inducible laryngeal obstruction","volume":"236","author":"Donohue","year":"2025","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.108736_bib100","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2022-001199","article-title":"Systematic review of the effectiveness of non-pharmacological interventions used to treat adults with inducible laryngeal obstruction","volume":"9","author":"Haines","year":"2022","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.rmed.2026.108736_bib101","series-title":"Exploring Factors Impacting Engagement in Speech Pathology Intervention for Inducible Laryngeal Obstruction","author":"Mahoney","year":"2024"},{"issue":"3","key":"10.1016\/j.rmed.2026.108736_bib102","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/cea.14036","article-title":"Treatment effectiveness for Vocal Cord Dysfunction in adults and adolescents: a systematic review","volume":"52","author":"Mahoney","year":"2022","journal-title":"Clin. Exp. Allergy"},{"issue":"7","key":"10.1016\/j.rmed.2026.108736_bib103","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/resp.13134","article-title":"Multidimensional assessment of severe asthma: a systematic review and meta-analysis","volume":"22","author":"Clark","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.rmed.2026.108736_bib104","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.rmed.2019.02.008","article-title":"Sputum proteomic signature of gastro-oesophageal reflux in patients with severe asthma","volume":"150","author":"Tariq","year":"2019","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2026.108736_bib105","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2147\/POR.S424098","article-title":"Development of an asthma exacerbation risk prediction model for conversational use by adults in England","volume":"14","author":"Kallis","year":"2023","journal-title":"Pragmatic Observational Res."},{"issue":"1","key":"10.1016\/j.rmed.2026.108736_bib106","doi-asserted-by":"crossref","DOI":"10.1111\/pai.13655","article-title":"Gastroesophageal reflux disease and asthma exacerbation: a systematic review and meta-analysis","volume":"33","author":"Mallah","year":"2022","journal-title":"Pediatr. Allergy Immunol."},{"issue":"2","key":"10.1016\/j.rmed.2026.108736_bib107","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01634-2021","article-title":"Vulnerability to acid reflux of the airway epithelium in severe asthma","volume":"60","author":"Perotin","year":"2022","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.rmed.2026.108736_bib108","first-page":"CD001496","article-title":"Pharmacological and surgical interventions for the treatment of gastro-oesophageal reflux in adults and children with asthma","volume":"5","author":"Kopsaftis","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.rmed.2026.108736_bib109","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jaci.2003.10.010","article-title":"Association between asthma and rhinitis according to atopic sensitization in a population-based study","volume":"113","author":"Leynaert","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"issue":"11","key":"10.1016\/j.rmed.2026.108736_bib110","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1034\/j.1398-9995.2002.23664.x","article-title":"The link between allergic rhinitis and allergic asthma: a prospective population-based study. The Copenhagen Allergy Study","volume":"57","author":"Linneberg","year":"2002","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.rmed.2026.108736_bib111","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.anai.2023.08.021","article-title":"Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry","volume":"132","author":"Scelo","year":"2024","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.rmed.2026.108736_bib112","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2147\/JAA.S81541","article-title":"United airway disease: current perspectives","volume":"9","author":"Giavina-Bianchi","year":"2016","journal-title":"J. Asthma Allergy"},{"issue":"6","key":"10.1016\/j.rmed.2026.108736_bib113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179125","article-title":"Computational analysis of multimorbidity between asthma, eczema and rhinitis","volume":"12","author":"Aguilar","year":"2017","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.rmed.2026.108736_bib114","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1111\/all.14314","article-title":"A novel whole blood gene expression signature for asthma, dermatitis, and rhinitis multimorbidity in children and adolescents","volume":"75","author":"Lemonnier","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2026.108736_bib115","article-title":"Transcriptomic analysis of asthma and allergic rhinitis reveals CST1 as a biomarker of unified airways","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.rmed.2026.108736_bib116","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaci.2019.06.049","article-title":"Next-generation Allergic Rhinitis and its impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence","volume":"145","author":"Bousquet","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.rmed.2026.108736_bib117","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41533-024-00408-4","article-title":"The effect of allergic rhinitis treatment on asthma control: a systematic review","volume":"35","author":"Tameeris","year":"2025","journal-title":"NPJ Prim Care Respir Med"},{"issue":"1","key":"10.1016\/j.rmed.2026.108736_bib119","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-20657-8","article-title":"Obesity and weight change during eight years in relation to asthma incidence","volume":"15","author":"Abohalaka","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.rmed.2026.108736_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103163","article-title":"Association between BMI and asthma in adults over 45 years of age: analysis of Global Burden of Disease 2021, China Health and Retirement Longitudinal Study, and National Health and Nutrition Examination Survey data","volume":"82","author":"Kong","year":"2025","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.rmed.2026.108736_bib121","series-title":"Obesity","first-page":"325","author":"Hinks","year":"2025"},{"issue":"7905","key":"10.1016\/j.rmed.2026.108736_bib122","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41586-022-04536-0","article-title":"Obesity alters pathology and treatment response in inflammatory disease","volume":"604","author":"Bapat","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.rmed.2026.108736_bib123","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s10020-023-00702-w","article-title":"Leptin\/obR signaling exacerbates obesity-related neutrophilic airway inflammation through inflammatory M1 macrophages","volume":"29","author":"Wang","year":"2023","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.108736_bib124","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00528-2020","article-title":"Treatment options in type-2 low asthma","volume":"57","author":"Hinks","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.rmed.2026.108736_bib125","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1007\/s12325-025-03175-x","article-title":"The real-world impact of glucagon-like peptide 1 receptor agonists on asthma control in people with high-risk asthma and obesity","volume":"42","author":"Kaplan","year":"2025","journal-title":"Adv. Ther."},{"issue":"7","key":"10.1016\/j.rmed.2026.108736_bib126","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1164\/rccm.202004-0993OC","article-title":"Asthma exacerbations in patients with type 2 diabetes and asthma on glucagon-like Peptide-1 receptor agonists","volume":"203","author":"Foer","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"11","key":"10.1016\/j.rmed.2026.108736_bib127","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1111\/all.14879","article-title":"Glucagon-like peptide-1 receptor agonist inhibits aeroallergen-induced activation of ILC2 and neutrophilic airway inflammation in obese mice","volume":"76","author":"Toki","year":"2021","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.rmed.2026.108736_bib128","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1183\/09031936.00073312","article-title":"Smoking and asthma: dangerous liaisons","volume":"41","author":"Polosa","year":"2013","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.rmed.2026.108736_bib130","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.amepre.2022.01.015","article-title":"Association between E-Cigarettes and asthma in adolescents: a systematic review and meta-analysis","volume":"62","author":"Li","year":"2022","journal-title":"Am. J. Prev. Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.108736_bib131","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-024-01013-x","article-title":"A systematic review and meta-analysis of the association between e-cigarette use among non-tobacco users and initiating smoking of combustible cigarettes","volume":"21","author":"Kim","year":"2024","journal-title":"Harm Reduct. J."},{"issue":"10","key":"10.1016\/j.rmed.2026.108736_bib132","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.202202-0373OC","article-title":"Biomarkers of airway immune homeostasis differ significantly with generation of E-Cigarettes","volume":"206","author":"Hickman","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"12","key":"10.1016\/j.rmed.2026.108736_bib133","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1016\/j.jaip.2025.07.049","article-title":"Impact of demographics on mepolizumab effectiveness in severe asthma: one-year REALITI-A subanalysis","volume":"13","author":"Chupp","year":"2025","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"5","key":"10.1016\/j.rmed.2026.108736_bib134","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jaip.2025.01.005","article-title":"Impact of smoking on biological treatment response in patients from the German severe asthma (GAN) registry","volume":"13","author":"Stoshikj","year":"2025","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmed.2026.108736_bib135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/JAA.S32232","article-title":"Asthma and obesity: does weight loss improve asthma control? A systematic review","author":"Ulrik","year":"2012","journal-title":"J. Asthma Allergy"},{"issue":"5","key":"10.1016\/j.rmed.2026.108736_bib136","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1183\/09031936.00053413","article-title":"Effects of weight loss on asthma control in obese patients with severe asthma","volume":"43","author":"Dias-J\u00fanior","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2026.108736_bib137","doi-asserted-by":"crossref","DOI":"10.1111\/cob.12556","article-title":"Dietary weight loss intervention provides improvement of gastroesophageal reflux disease symptoms-A randomized clinical trial","volume":"13","author":"Valentini","year":"2023","journal-title":"Clin Obes"},{"issue":"2","key":"10.1016\/j.rmed.2026.108736_bib138","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/bcp.15002","article-title":"A Phase 1 study of the long-acting anti-IL-5 monoclonal antibody GSK3511294 in patients with asthma","volume":"88","author":"Singh","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"24","key":"10.1016\/j.rmed.2026.108736_bib139","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1056\/NEJMoa2406673","article-title":"Twice-Yearly depemokimab in severe asthma with an eosinophilic phenotype","volume":"391","author":"Jackson","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2026.108736_bib141","first-page":"183","article-title":"FRONTIER-3: a randomised phase 2a study to investigate tozorakimab (an anti-IL-33 mAb) in early onset asthma","author":"Corren","year":"2025","journal-title":"ERJ Open Research"},{"issue":"18","key":"10.1016\/j.rmed.2026.108736_bib142","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa2024257","article-title":"Efficacy and safety of itepekimab in patients with moderate-to-severe asthma","volume":"385","author":"Wechsler","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.rmed.2026.108736_bib143","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaci.2021.03.044","article-title":"Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: a randomized clinical trial","volume":"148","author":"Kelsen","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.rmed.2026.108736_bib144","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13864","article-title":"A first-in-human, single and multiple dose study of lunsekimig, a novel anti-TSLP\/anti-IL-13 NANOBODY\u00ae compound, in healthy volunteers","volume":"17","author":"Deiteren","year":"2024","journal-title":"Clin. Transl. Sci."},{"issue":"3","key":"10.1016\/j.rmed.2026.108736_bib147","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01193-2022","article-title":"Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma","volume":"61","author":"Gauvreau","year":"2023","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2026.108736_bib148","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12931-025-03309-3","article-title":"ARTEMISIA: a mechanistic study of a novel Janus kinase 1 inhibitor to advance molecular understanding and precision medicine in asthma","volume":"26","author":"Dosanjh","year":"2025","journal-title":"Respir. Res."},{"issue":"12","key":"10.1016\/j.rmed.2026.108736_bib151","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1007\/s13555-024-01308-8","article-title":"A narrative review of the OX40-OX40L pathway as a potential therapeutic target in atopic dermatitis: focus on rocatinlimab and Amlitelimab","volume":"14","author":"Abdelhalim","year":"2024","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.rmed.2026.108736_bib152","article-title":"Dose ranging Study of Amlitelimab in adult participants with moderate-to-severe asthma","year":"2025","journal-title":"TIDE-asthma)"},{"issue":"5","key":"10.1016\/j.rmed.2026.108736_bib154","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.jaci.2023.12.008","article-title":"BTK signaling-a crucial link in the pathophysiology of chronic spontaneous urticaria","volume":"153","author":"Bernstein","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2026.108736_bib155","first-page":"OA2774","article-title":"Late Breaking Abstract - efficacy of high- and low-dose rilzabrutinib from a phase 2 study","volume":"64","author":"Pavord","year":"2024","journal-title":"Eur. Respir. J."},{"issue":"20","key":"10.1016\/j.rmed.2026.108736_bib156","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1056\/NEJMoa1613125","article-title":"KIT inhibition by imatinib in patients with severe refractory asthma","volume":"376","author":"Cahill","year":"2017","journal-title":"N. Engl. J. Med."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126001046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126001046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T13:14:54Z","timestamp":1774358094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611126001046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":148,"alternative-id":["S0954611126001046"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.108736","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatable traits and treatment options in asthma","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.108736","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108736"}}